180 related articles for article (PubMed ID: 37436963)
1. Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs.
Williams EA; Ravindranathan A; Gupta R; Stevers NO; Suwala AK; Hong C; Kim S; Yuan JB; Wu J; Barreto J; Lucas CG; Chan E; Pekmezci M; LeBoit PE; Mully T; Perry A; Bollen A; Van Ziffle J; Devine WP; Reddy AT; Gupta N; Basnet KM; Macaulay RJB; Malafronte P; Lee H; Yong WH; Williams KJ; Juratli TA; Mata DA; Huang RSP; Hiemenz MC; Pavlick DC; Frampton GM; Janovitz T; Ross JS; Chang SM; Berger MS; Jacques L; Song JS; Costello JF; Solomon DA
Neuro Oncol; 2023 Dec; 25(12):2221-2236. PubMed ID: 37436963
[TBL] [Abstract][Full Text] [Related]
2. Stringent comparative sequence analysis reveals SOX10 as a putative inhibitor of glial cell differentiation.
Gopinath C; Law WD; Rodríguez-Molina JF; Prasad AB; Song L; Crawford GE; Mullikin JC; Svaren J; Antonellis A
BMC Genomics; 2016 Nov; 17(1):887. PubMed ID: 27821050
[TBL] [Abstract][Full Text] [Related]
3. Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
Röhrich M; Koelsche C; Schrimpf D; Capper D; Sahm F; Kratz A; Reuss J; Hovestadt V; Jones DT; Bewerunge-Hudler M; Becker A; Weis J; Mawrin C; Mittelbronn M; Perry A; Mautner VF; Mechtersheimer G; Hartmann C; Okuducu AF; Arp M; Seiz-Rosenhagen M; Hänggi D; Heim S; Paulus W; Schittenhelm J; Ahmadi R; Herold-Mende C; Unterberg A; Pfister SM; von Deimling A; Reuss DE
Acta Neuropathol; 2016 Jun; 131(6):877-87. PubMed ID: 26857854
[TBL] [Abstract][Full Text] [Related]
4. The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion.
Graf SA; Heppt MV; Wessely A; Krebs S; Kammerbauer C; Hornig E; Strieder A; Blum H; Bosserhoff AK; Berking C
Pigment Cell Melanoma Res; 2019 May; 32(3):424-434. PubMed ID: 30506895
[TBL] [Abstract][Full Text] [Related]
5. SOX10 transactivates S100B to suppress Schwann cell proliferation and to promote myelination.
Fujiwara S; Hoshikawa S; Ueno T; Hirata M; Saito T; Ikeda T; Kawaguchi H; Nakamura K; Tanaka S; Ogata T
PLoS One; 2014; 9(12):e115400. PubMed ID: 25536222
[TBL] [Abstract][Full Text] [Related]
6. Activation of Krox20 gene expression by Sox10 in myelinating Schwann cells.
Reiprich S; Kriesch J; Schreiner S; Wegner M
J Neurochem; 2010 Feb; 112(3):744-54. PubMed ID: 19922439
[TBL] [Abstract][Full Text] [Related]
7. Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage.
Finzsch M; Schreiner S; Kichko T; Reeh P; Tamm ER; Bösl MR; Meijer D; Wegner M
J Cell Biol; 2010 May; 189(4):701-12. PubMed ID: 20457761
[TBL] [Abstract][Full Text] [Related]
8. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
[TBL] [Abstract][Full Text] [Related]
9. SOX10-regulated promoter use defines isoform-specific gene expression in Schwann cells.
Fogarty EA; Kitzman JO; Antonellis A
BMC Genomics; 2020 Aug; 21(1):549. PubMed ID: 32770939
[TBL] [Abstract][Full Text] [Related]
10. Desert hedgehog links transcription factor Sox10 to perineurial development.
Küspert M; Weider M; Müller J; Hermans-Borgmeyer I; Meijer D; Wegner M
J Neurosci; 2012 Apr; 32(16):5472-80. PubMed ID: 22514309
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases.
Lasota J; Wasag B; Dansonka-Mieszkowska A; Karcz D; Millward CL; Ryś J; Stachura J; Sobin LH; Miettinen M
Lab Invest; 2003 Sep; 83(9):1361-71. PubMed ID: 13679444
[TBL] [Abstract][Full Text] [Related]
12. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma.
Agnihotri S; Gugel I; Remke M; Bornemann A; Pantazis G; Mack SC; Shih D; Singh SK; Sabha N; Taylor MD; Tatagiba M; Zadeh G; Krischek B
J Neurosurg; 2014 Dec; 121(6):1434-45. PubMed ID: 25245477
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of SOX10 to distinguish malignant peripheral nerve sheath tumor from synovial sarcoma, including intraneural synovial sarcoma.
Kang Y; Pekmezci M; Folpe AL; Ersen A; Horvai AE
Mod Pathol; 2014 Jan; 27(1):55-61. PubMed ID: 23929265
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of chromosome 22 deletions in schwannomas.
Bijlsma EK; Brouwer-Mladin R; Bosch DA; Westerveld A; Hulsebos TJ
Genes Chromosomes Cancer; 1992 Oct; 5(3):201-5. PubMed ID: 1384671
[TBL] [Abstract][Full Text] [Related]
15. Molecular Analysis of Hybrid Neurofibroma/Schwannoma Identifies Common Monosomy 22 and α-T-Catenin/CTNNA3 as a Novel Candidate Tumor Suppressor.
Stahn V; Nagel I; Fischer-Huchzermeyer S; Oyen F; Schneppenheim R; Gesk S; Bohring A; Chikobava L; Young P; Gess B; Werner M; Senner V; Harder A
Am J Pathol; 2016 Dec; 186(12):3285-3296. PubMed ID: 27765635
[TBL] [Abstract][Full Text] [Related]
16. SWI/SNF enzymes promote SOX10- mediated activation of myelin gene expression.
Marathe HG; Mehta G; Zhang X; Datar I; Mehrotra A; Yeung KC; de la Serna IL
PLoS One; 2013; 8(7):e69037. PubMed ID: 23874858
[TBL] [Abstract][Full Text] [Related]
17. Mutations affecting BRAF, EGFR, PIK3CA, and KRAS are not associated with sporadic vestibular schwannomas.
de Vries M; Bruijn IB; Cleton-Jansen AM; Malessy MJ; van der Mey AG; Hogendoorn PC
Virchows Arch; 2013 Feb; 462(2):211-7. PubMed ID: 23224067
[TBL] [Abstract][Full Text] [Related]
18. Disrupted SOX10 function causes spongiform neurodegeneration in gray tremor mice.
Anderson SR; Lee I; Ebeling C; Stephenson DA; Schweitzer KM; Baxter D; Moon TM; LaPierre S; Jaques B; Silvius D; Wegner M; Hood LE; Carlson G; Gunn TM
Mamm Genome; 2015 Feb; 26(1-2):80-93. PubMed ID: 25399070
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells.
Bian LG; Sun QF; Tirakotai W; Zhao WG; Shen JK; Luo QZ; Bertalanffy H
Chin Med J (Engl); 2005 Sep; 118(18):1517-24. PubMed ID: 16232328
[TBL] [Abstract][Full Text] [Related]
20. Sox10: a pan-schwannian and melanocytic marker.
Nonaka D; Chiriboga L; Rubin BP
Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
